Anthony Pagano

EVP & CFO at Genmab

Mr. Pagano joined Genmab in 2007 and was appointed Senior Vice President in 2011. In 2020 he was promoted to Executive Vice President & Chief Financial Officer. Prior to joining Genmab, Mr. Pagano was Corporate Controller and Senior Director of Business Planning at NovaDel Pharma, a publicly-traded specialty pharmaceutical company. He started his career at KPMG LLP, reaching the position of Manager, where he provided audit and M&A consulting services to clients ranging from start-ups to Fortune 500s in a broad range of industries. He is a Certified Public Accountant and received a B.S. in Accounting from The College of New Jersey, as well as an M.B.A. from the Stern School of Business at New York University.

Location

Princeton, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Genmab

40 followers

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


Industries

Employees

1,001-5,000

Links